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Saccharomyces cerevisiae mutants lacking two of the three DNA
helicases Sgs1, Srs2, and Rrm3 exhibit slow growth that is sup-
pressed by disrupting homologous recombination. Cells lacking
Sgs1 and Rrm3 accumulate gross-chromosomal rearrangements
(GCRs) that are suppressed by the DNA damage checkpoint and by
homologous recombination-defective mutations. In contrast, rrm3,
srs2, and srs2 rrm3 mutants have wild-type GCR rates. GCR types in
helicase double mutants include telomere additions, transloca-
tions, and broken DNAs healed by a complex process of hairpin-
mediated inversion. Spontaneous activation of the Rad53 check-
point kinase in the rrm3 mutant depends on the Mec3Rad24 DNA
damage sensors and results from activation of the Mec1Rad9-
dependent DNA damage response rather than the Mrc1-dependent
replication stress response. Moreover, helicase double mutants
accumulate Rad51-dependent Ddc2 foci, indicating the presence of
recombination intermediates that are sensed by checkpoints.
These findings demonstrate that different nonreplicative helicases
function at the interface between replication and repair to main-
tain genome integrity.
checkpoints  genome instability  RRM3  SGS1
In Saccharomyces cerevisiae, the DNA helicases Sgs1, Srs2, andRrm3 are thought to be important for the maintenance of
genome stability. Mutations in any two of these helicase genes
cause slow growth that is suppressed by inhibiting homologous
recombination (HR). This has been interpreted as suggesting
that these helicases constitute a network of partially functionally
redundant proteins that act to prevent the deleterious effects of
some type of replication error possibly including inherent insta-
bility of the replication machinery leading to toxic DNA struc-
tures formed by HR proteins (1–5).
Sgs1 is the only RecQ-family, 3-to-5 helicase in S. cerevisiae.
Sgs1 acts in the coordination between replication and HR, in the
suppression of homeologous recombination, in the suppression of
crossover products during HR, in S-phase checkpoint activation,
and in transcription (6–11). Cells that lack Sgs1 are hyperrecom-
binogenic and sensitive toDNA-damaging agents such as hydroxyu-
rea and methyl-methanesulfonate, and they accumulate rDNA
circles, missegregate chromosomes, and have modestly increased
gross-chromosomal rearrangement (GCR) rates (11–15). Muta-
tions in human RecQ-like helicases, such as WRN (16), BLM (17),
and RECQ4 (18), cause Werner, Bloom’s, and Type-II-Rothmund
Thomson syndromes, respectively, characterized by a predisposition
to cancer andor accelerated aging. RecQ-family helicases interact
with proteins important for genome stability, such as Rad51 (19)
and RPA (20–22), as well as with proteins that function in DNA-
damage response pathways (7, 10, 23). Consistent with these
findings, sgs1 mutants show incomplete activation of the Rad53
checkpoint kinase in response to DNA-damaging agents (7, 24, 25).
Srs2 is a 3-to-5 DNA helicase with similarity to the bacterial
Rep and UvrD helicases (26, 27). Srs2 removes Rad51 from
single-stranded DNA in vitro, and this is believed to underlie the
role of Srs2 as an antirecombinase (28–30). A role for Srs2 in
the prevention of aberrantHR is supported by genetic evidence that
the hyperrecombination andDNA-damage sensitive phenotypes of
srs2 mutants are suppressed by HR defects (31). The physical
interaction between Srs2 and Pol32, a structural subunit of DNA
polymerase delta, suggests that Srs2 may act during DNA replica-
tion (32). Srs2 also is required for proper activation of Rad53 in
response to DNA-damaging agents (7, 33), and Srs2 itself is
phosphorylated after cells are exposed to methyl-methanesulfon-
ate, hydroxyurea, or UV light; however, the significance of this
phosphorylation is unknown (33).
Unlike Sgs1 and Srs2, the Rrm3 helicase has 5-to-3 polarity and
shares homology throughout its helicase domain with the S. cer-
evisiaeDNAhelicase Pif1 (34). Cells lackingRrm3exhibit increased
recombination at the rDNA locus and at other tandem repeats (35).
The physical interaction between Rrm3 and the replication protein
proliferating cell nuclear antigen as well as the role of Rrm3 in
preventing genome-wide unscheduled replication fork pausing sug-
gest that Rrm3 acts during DNA replication (34, 36, 37). Roles in
replication through telomeric and subtelomeric DNA and in sup-
pression of Ty1 transposition also have been assigned to Rrm3 (38,
39). Interestingly, Rad53 is partially activated in rrm3mutants (37).
sgs1 rrm3, sgs1 srs2, and srs2 rrm3 double mutants exhibit growth
defects that are suppressed by mutations in RAD51, RAD55, or
RAD57; this has been interpreted to suggest that the helicase double
mutants accumulate toxic HR intermediates, such as Holliday
junctions. Holliday junctions are typically thought to form during
double-strand break repair (40, 41); however, they also are gener-
ated during DNA replication in Escherichia coli as a result of fork
pausing, establishing a link between replication and recombination
(42). Coupling of replication fork pausing to recombination also is
supported by the finding in S. cerevisiae that pausing at the
replication-fork barrier in rDNA stimulates recombinational events
nearby (43). Spikes of X-shaped molecules identified on 2D gels,
which have been interpreted as Holliday junctions because their
formation depends on the recombination protein Rad52, are
stronger in S-phase than in any other phase of the vegetative cell
cycle of S. cerevisiae and may result from repair of replication-
related DNA lesions by recombination between sister chromatids
(44). X-shaped molecules also are observed in rrm3 mutants,
suggesting a link between joint molecule formation and replication
fork pausing in the absence of the Rrm3 (39). Rad51-dependent
X-shaped DNA also accumulates in methyl-methanesulfonate-
treated sgs1 mutants, suggesting that Sgs1 facilitates the resolution
of these HR intermediates or prevents their formation (25). How-
ever, a relationship between replication-dependent Holliday junc-
tions and other branched, aberrant replication-associated DNA
structures or brokenDNAshas not yet been established. In addition
to dissociating Holliday junctions and G4-DNA in vitro (45, 46),
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BLM, the human RecQ-like helicase most closely related to Sgs1,
also has been shown to melt D-loops formed between oligonucle-
otides in vitro (47).
In the present study, we have analyzed GCRs and checkpoint
activation in recombination andor checkpoint-defective cells lack-
ing one or more helicases. We found that the helicase double
mutants accumulate DNA damage foci and that their frequency is
decreased in the absence ofRad51.Weobserved an increasedGCR
rate in cells lacking Sgs1 and Rrm3 but not in cells lacking Srs2 and
Rrm3, underlining fundamental differences between the roles of
these helicases in the maintenance of genome stability. Finally, we
present evidence that GCRs in sgs1 rrm3 mutants result from HR
and are suppressed by the DNA damage checkpoint response.
Results
GCRs in Helicase Mutants Are Promoted by HR and Suppressed by the
DNA Damage Checkpoint. Cells lacking Sgs1 accumulate GCRs at a
moderate rate (11). To gain further insight into the cause of the
slow-growth phenotype and decreased viability of helicase double
mutants, we examined the accumulation of GCRs in rrm3, srs2, and
sgs1 single mutants and in strains with multiple helicase defects. In
contrast to an sgs1mutant, rrm3 and srs2 singlemutants and an rrm3
srs2 double mutant did not have increased GCR rates compared
withwild type (Table 1).However, the rrm3 sgs1 doublemutant had
an increased GCR rate compared with the sgs1 single mutant (P
0.0018). Because helicase double mutants with an additional dele-
tion of RAD51 or RAD55 grow normally, we measured the GCR
rates of rrm3 sgs1 rad51 and rrm3 sgs1 rad55mutants and observed
a reduction in GCR rates compared with the rrm3 sgs1 double
mutant (P  0.0001; Table 1). In contrast to a RAD51 deletion,
deletion of the DNA damage checkpoint genes MEC3 or RAD24
led to increases in theGCRrate of the sgs1 rrm3mutant (P 0.0007
and P  0.0025, respectively). This finding suggests that aberrant
HR initiates most of the GCRs in rrm3 sgs1mutants, which can be
prevented if the DNA damage checkpoints are functional.
Next we sequenced the breakpoints of the GCRs formed in the
rrm3 sgs1 and rrm3 sgs1 mec3 mutants (Table 2; see also Table 3,
which is published as supporting information on the PNAS web
Table 1. Effect of helicase, homologous recombination, and checkpoint defects on the rate of accumulation of GCRs
Wild type rad51 rad55 mec3 rad24
Relevant
genotype
RDKY
strain
Mutation
rate
RDKY
strain
Mutation
rate
RDKY
strain
Mutation
rate
RDKY
strain
Mutation
rate
RDKY
strain
Mutation
rate
Wild type 3615 3.5 (1) 5559 8 (2.3) 5565 71 (20) 5569 17 (5) 5573 23 (7)
rrm3 5556 14 (4) 5560 13 (4) 5566 119 (34) 5570 18 (5) 5574 18 (5)
srs2 5557 2.2 (0.6) 5561 17 (5) ND 5571 23 (7) ND
sgs1 5558 77 (22) 5562 35 (10) 5567 289 (82) 5572 339 (97) 5575 136 (39)
rrm3 srs2 5576* 10 (3) 5563 51 (15) ND 5578* 290 (83) ND
rrm3 sgs1 5577* 656 (187) 5564 15 (4) 5568 76 (22) 5579† 1,942 (555) 5580 1687 (482)
Mutation rates (Canr 5-FOAr 1010) were calculated as described previously (68) by determining the number of cells that are resistant to canavanine (Canr)
and 5-fluoroorotic acid (5-FOAr) due to coinactivation of the CAN1 and URA3 genes on chromosome 5. The numbers in parentheses indicate the increase of the
GCR rate relative to wild type. ND, not determined.
*Haploid strains containing mutations of interest were freshly obtained by sporulation of RDKY5576, RDKY5577 and RDKY5578.
†Freshly obtained spores had a GCR rate (8  107) that was slightly higher, although similar to the haploid strain RDKY5579.
Table 2. Rates of GCR types
GCR rate
Translocation
Relevant
genotype RDKY strain Telomere addition NH MH Other
Wild type* 3,615 2.9 (1417) 0.6 (317) 0.2 (017) 0.2 (017)
mec3† 5,569 14 (810) 1.7 (010) 3.4 (210) 1.7 (010)
sgs1‡ 5,558 48 (1016) 10 (216) 19 (416) 5 (016)
rrm3 sgs1 5,576 358 (611) 60 (011) 239 (411) 60 (111)§
rrm3 sgs1 mec3 5,579 242 (18) 242 (08) 1456 (68) 242 (18)¶
Mutation rates (Canr 5-FOAr  1010) were calculated as described for Table 1. Rates of GCR types were determined by multiplying
the fractions of the total that a particular rearrangement represents by the GCR rate of the corresponding strain. Significant differences
in GCR type rates were seen between the sgs1 and sgs1 rrm3 mutants for de novo telomere additions (P  0.0008) and translocations
with microhomology (P 0.0001) and between the rrm3 sgs1 and rrm3 sgs1 mec3 mutants for translocations with microhomology (P
0.0001). In a PCR screen of 41 sgs1 rrm3 mutants, four GCR rearrangements were found in which the URA3 gene was deleted and the
CAN1 ORF was present, suggesting independent inactivation of the two genes. Inactivating point mutations in CAN1 could only be
identified in three of the four isolates (E76STOP, Q298H, and DEL760G); the chromosome V breakpoints have not yet been mapped. For
the rrm3 sgs1 mec3 mutants, one GCR rearrangement was found in which the wild-type ORF of URA3 is present and a I534V mutation
was identified in the CAN1 gene. The last 88 bp of the CAN1 ORF could not be amplified, indicative of a partial gene deletion. There
is no evidence that I534V inactivates the Can1 protein. The chromosomal breakpoint was not further identified. MH, microhomology;
NH, nonhomology.
*See refs. 48 and 50.
†See ref. 49.
‡See ref. 11.
§Translocation (NH) with a 1-nt insertion at the breakpoint.
¶Telomere addition on chromosome V after nucleotides 34312–34317 were deleted and nucleotides 34290–34311 were inverted (see
text, Table 3, and Fig. 5 for further description).
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site). Translocations in the rrm3 sgs1 and rrm3 sgs1 mec3 mutants
occurred exclusively between regions with microhomologies (Table
2), consistent with a dependency on HR. Deletion of RRM3 in the
sgs1 mutant led to an increase in the rate of translocations with
microhomologies (P 0.0001). Deletion ofMEC3 in the sgs1 rrm3
mutant increased the translocation rate further by 5-fold (P 
0.0001), which indicates that the DNA damage checkpoint acts in
suppressing translocations. In contrast, Mec3 was not required for
prevention of de novo telomere additions in the sgs1 rrm3 mutant
(P 0.19). Sequencing of six translocation junctions isolated from
the rrm3 sgs1 mec3 mutant revealed one translocation between
chromosome V (nucleotide 34074) and chromosome XIV (nucle-
otide 779339), one translocation between chromosome V (nucle-
otide 32662) and a Y element, and four translocations between the
CAN1 gene on chromosome V and a CAN1-related gene, either
LYP1 orALP1, on chromosomeXIV (Tables 2 and 3). The detailed
investigation of homeology-driven translocations between CAN1
and CAN1-related genes in various sgs1 mutants is reported else-
where (51). In addition to translocations and telomere additions, we
identified a complex rearrangement in the rrm3 sgs1 mec3 mutant
that consists of an inversion of 22 nt on chromosomeV (nucleotides
34290–34312) followed by a de novo telomere addition (Table 3; see
also Fig. 5, which is published as supporting information on the
PNAS web site).
Normal Growth of HR-Defective sgs1 rrm3 Mutants Depends on the
DNA Damage Checkpoint Sensor Mec3. sgs1 rrm3 mutants have a
severe growth defect that can be rescued by RAD51 or RAD55
deletions (4, 5, 52). This rescue appears to also depend on the HR
proteinRad59 (5), which is thought to promote aRad52-dependent
HR process that requires shorter homologies than Rad51 (53). The
rescue of the sgs1 rrm3 slow growth phenotype by a rad51mutation
also depends on theDNAdamage checkpoint sensorMec3 (Fig. 1).
sgs1 rrm3 double mutants also have an increased GCR rate that is
reduced by deletion of RAD51, and this reduction in the GCR rate
was reversed by deletion of MEC3, with the GCR rate of the sgs1
rrm3 rad51 mec3 mutant being equal to the GCR rate of the sgs1
rrm3 mec3mutant (51), suggesting that normal growth and the low
GCR rate of sgs1 rrm3 rad51 mutants require the DNA damage
checkpoint.
Increased Frequency of Ddc2 Foci in Helicase Mutants Is Rad51-
Dependent.The increasedGCR rate seen in sgs1 rrm3 and rrm3 srs2
mutants that lack Rad24 or Mec3 suggests that helicase double
mutants suffer spontaneous DNA damage during replication that
is sensed by the DNA damage checkpoint, thereby preventing it
from engaging in aberrant repair processes. Ddc2, a checkpoint
protein that associates withMec1, relocalizes from a diffuse nuclear
distribution into distinct, Mec1-dependent foci after exposure to
exogenous DNA-damaging agents or after accumulation of endog-
enousDNAdamage (54–56). To assess checkpoint activation in the
sgs1 rrm3 double mutant, we tagged the endogenous copy ofDDC2
with GFP and inspected unsynchronized live cells for assembly of
Ddc2 foci. Mostly one Ddc2 focus appeared in 9–15% of wild-type
cells and helicase or HR single mutants (Fig. 2). One to three Ddc2
foci were found in helicase double mutants, and the percentage of
cells with Ddc2 foci increased to 39–60% (Fig. 2). Deletion
of RAD51 in these helicase double mutants decreased the number
of cells with Ddc2 foci to a level similar to that of HR-deficient
helicase single mutants. This finding suggests that HR intermedi-
ates that are generated at lesions formed during DNA replication
due to lack of Sgs1, Srs2, and Rrm3 are mostly responsible for the
increased frequency of Ddc2 foci in helicase double mutants.
Rad53 Phosphorylation in the Absence of Rrm3 Depends on the DNA
Damage Checkpoint. Replication forks are known to pause fre-
quently at specific sites throughout the genomeof rrm3mutants (34,
37, 39), and it is thought that this defect contributes to the slow
growth phenotype and increased cell death exhibited by rrm3
mutants that also lack Sgs1 or Srs2. Consistent with this, phosphor-
ylation of Rad53 occurs in rrm3 mutants and persists in rrm3 sgs1
and rrm3 sgs1 rad51 mutants (57). This raises the possibility that
replication fork stalling in rrm3 mutants, although insufficient to
cause genome instability on its own (Table 1), results in genome
instability when cellular processes that combat the deleterious
effects of stalled replication forks, such as Sgs1-dependent mech-
anisms, are defective.
To test the functional significance of Rad53 activation in the
absence of Rrm3, we introduced the checkpoint mutations mec3,
mec1, rad24, dbp11-1,mrc1, rad9, chk1, dun1, and pds1 into an rrm3
mutant. Only MRC1 was found to be essential for viability of the
rrm3 mutant (Fig. 3 and data not shown) and, consistent with a
previous report, MEC1 was required for viability at 20°C (37).
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Fig. 1. Normal growth of an HR-defective sgs1 rrm3 mutant depends on the
DNA-damage checkpoint sensor Mec3. Cells are shown after incubation at
30°C for 2 days on yeast extractpeptonedextrose media. The doubling time
(t) of the sgs1 rrm3 mutant was 267  16 min.
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Fig. 2. Ddc2-GFP foci formation at spontaneous DNA damage in helicase
double mutants depends on homologous recombination. Quantification of
Ddc2-GFP foci in living cells containing helicase mutations andor a deletion
of RAD51. From at least two cell cultures 200–500 cells were analyzed for the
presence of foci. Strains were obtained by sporulation of the appropriate
diploid strains just before analysis (see Materials andMethods). For images of
Ddc2-GFP foci in living cells containing deletions of SGS1, RRM3, SRS2, SGS1,
and RRM3; SGS1 and SRS2; or RRM3 and SRS2 (see Fig. 6, which is published as
supporting information on the PNAS web site).
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MRC1 encodes a Claspin-like protein with roles in DNA replica-
tion, establishment of sister-chromatid cohesion, and S-phase
checkpoint activation (58–61). Mrc1 moves with the replication
fork and acts as mediator of replication stress in a Rad9-
independent pathway of Rad53 activation and phosphorylation
(58–60). Cells lacking Mrc1 are unable to fully activate Rad53 in
response to replication stress caused by hydroxyurea treatment,
whereas they are fully capable of activating Rad53 in response to
DNA damage generated by a cdc13-1 mutation. Because rrm3
mutants suffer from frequent replication fork pausing and exhibit
chronic Rad53 phosphorylation, we tested whether the checkpoint
function ofMrc1 was required for the survival of rrm3mutants. An
rrm3mutation was combined with anMRC1 allele (mrc1-AQ) that
is proficient for DNA replication but is defective for activation of
Rad53 in response to replication stress (59). The rrm3 mrc1-AQ
mutant showed normal growth, indicating that the replication
function but not the checkpoint function ofMrc1 is essential in rrm3
mutants (Fig. 3).
Rad53 is spontaneously phosphorylated in the absence of Rrm3
(37) but not in the absence of Sgs1 or Srs2 (Fig. 4A). Rad53 became
phosphorylated during S-phase in an rrm3 mutant, and this phos-
phorylationwas eliminated by the rad9mutation or by both the rad9
mutation and the mrc1-AQ mutation but not by the mrc1-AQ
mutation alone (Fig. 4B). Rad53 phosphorylation also depended on
the checkpoint kinase Mec1 and the DNA damage sensors Mec3
and Rad24 (Fig. 4C). These observations suggest that unscheduled
fork pausing by itself is not the major source of Rad53 phosphor-
ylation in rrm3 mutants. Instead, these results indicate that Rad53
phosphorylation in rrm3 mutants is mediated through the Mec3
Mec1Rad9-dependent DNA-damage response pathway and sug-
gests that Rad53 is activated in response to exposure of large
single-stranded regions at paused replication forks in rrm3mutants
andor the conversion of paused replication forks to double-strand
breaks. Rad53 was also phosphorylated in rrm3 sgs1 rad51 and rrm3
sgs1 rad55 mutants (Fig. 4C), indicating that recombination inter-
mediates are not the major activator of the DNA damage response
in these mutants.
Similar to the results obtained with mec3 and rad24 mutations
(Table 1), the rrm3 rad9 double mutant had essentially the same
GCR rate as the rrm3 and rad9 single mutants (3.7  109, 1.5 
109, and 2 109, respectively); these results suggest that neither
theDNAdamage checkpoint norRad53 activation accounts for the
low GCR rate of rrm3 mutants. Although the amount of DNA
damage in rrm3 mutants is sufficiently high to activate Rad53,
DNA-damage foci in rrm3mutants were rare. Thismay suggest that
DNA damage is very efficiently repaired in rrm3 mutants, in part
as a result of Rad53-dependent checkpoint activation, so that the
threshold of total DNA-damage required for the formation of
microscopically detectable Ddc2 foci is rarely reached in cells
lacking Rrm3. It should also be noted that the level of Rad53
phosphorylation seen in rrm3 mutants is not as extensive as seen
when cells are treated with agents like hydroxyurea or methyl-
methanesulfonate that result in full checkpoint activation.
Discussion
In this study, we provide evidence for distinct roles for Sgs1, Srs2,
and Rrm3 in the prevention of DNA damage and genome
instability. Whereas sgs1 mutants have a moderately increased
GCR rate, rrm3 and srs2mutants have wild-type levels of GCRs.
Rrm3 is required in the absence of Sgs1, but not in the absence
of Srs2, to prevent GCRs, such as de novo telomere additions and
translocations. The increased GCR rate exhibited by rrm3 sgs1
mutants is suppressed by HR-defective mutations but is elevated
by mec3 and rad24 mutations. In contrast, HR-defective muta-
rrm3 mrc1 rrm3 mrc1-AQ
Fig. 3. Cells lacking Rrm3 require Mrc1, but not its S-phase checkpoint
function, for viability. Tetrads obtained by sporulation of a diploid made by
crossing RDKY4714 and RDKY5553 (containing deletions of RRM3 and MRC1,
respectively) were dissected and genotyped; spores predicted to contain both
rrm3 and mrc1 mutations are absent. Tetrads obtained by sporulation of a
diploid made by crossing RDKY4714 and RDKY5554 (containing a deletion of
RRM3 and the mrc1-AQ allele, respectively) were dissected and genotyped;
rrm3 mrc1-AQ spores are viable. Double mutants are marked by a circle.
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Fig. 4. Rad53 phosphorylation in rrm3 mutants depends on Mec3, Rad24,
Rad9, and Mec1, but not on the S-phase checkpoint function of Mrc1. (A)
Rad53 is spontaneously phosphorylated in rrm3mutants but not in sgs1or srs2
mutants. Cells were arrested in G1 phase with -factor released from arrest by
transfer into fresh media. Aliquots were harvested just before release from
-factor arrest (time point 0) and after 30 min of continued incubation in fresh
media (time point 30). (B) Rad53 phosphorylation in rrm3mutants is cell-cycle-
dependent and Rad9-dependent but does not require the S-phase checkpoint
function of Mrc1. Log-phase cultures were released from G1 arrest (time point
0), and aliquots were removed every 15 min for 2 h. Rad53 protein was
detected on Western blots by using polyclonal Rad53 antibody (serum JDI47).
(C) Rad53 phosphorylation in rrm3 mutants also depends on the checkpoint
sensors Rad24 and Mec3 and the checkpoint kinase Mec1. Rad53 phosphor-
ylation in the rrm3 sgs1mutant is not abolished by a rad51 or rad55mutation,
which rescue the severe, slow-growth phenotype of the rrm3 sgs1 mutant.
Cells were treated as in A, and Rad53 protein was detected on Western blots
with monoclonal Rad53 antibody (serum EL7).
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tions did not affect the GCR rate of the srs2 rrm3 mutant but
deletion of MEC3 led to an increase in the GCR rate, although
the resulting GCR rate was much less than that of themec3 rrm3
sgs1 triple mutant. These differences highlight the distinct roles
of Sgs1, Rrm3, and Srs2 in safeguarding genome stability. The
different GCR rates may be due to a higher incidence of DNA
lesions in the absence of Sgs1 and Rrm3 but not in the absence
of Srs2. The lower GCR rate of the rrm3 mutant as compared
with the sgs1mutant, despite the fact that replication forks pause
frequently in rrm3 mutants, could be explained by a more
random distribution of DNA lesions in the absence of Sgs1,
whereas lesions in the rrm3 mutant may be more region-specific
(rDNA, subtelomeric DNA, Ty1 elements, and protein-bound
sequences) and thus may not occur frequently in the region of
chromosome V studied in our GCR assay. Alternatively, it is
possible that stalled replication forks per se do not lead to
genome instability either because they are not a deleterious form
of DNA damage or because cells have potent mechanisms that
repair them, including processes that require Sgs1. Additionally,
the ability of Sgs1 to prevent illegitimate recombination events
may prevent GCRs that might occur in srs2, rrm3, and srs2 rrm3
mutants. Alternatively, loss of Srs2, which has the ability to
disrupt Rad51-filamants in vitro (28, 29), may cause significant
deregulation of HR in the srs2 and srs2 rrm3mutants, which may
prevent the formation of intermediates that lead to viable GCRs.
The synergistic increase in the GCR rate in sgs1 rrm3 mutants
compared with the single mutants provides further evidence that
Sgs1 and Rrm3 act in parallel to prevent the formation of HR-
dependent DNA lesions during DNA replication that can lead to
GCRs. For example, Sgs1 may help replication forks pass through
sequences that can adopt unusual DNA structures (46, 62), it may
be involved in replication fork stabilization (10) andor it may act
on DNA structures such as Holliday junctions and branched DNA
structures that formduring replication fork pausing to facilitate fork
restart (63, 64). Replication fork pausing at specific sites throughout
the S. cerevisiae genome in rrm3 mutants indicates that Rrm3 may
help the replication fork bypass proteins that are complexed with
DNA ormay generally act to prevent aberrant DNA structures that
could form when replication forks pause (37, 39, 65); however,
either the level of fork pausing in rrm3 mutants or the structure of
the stalled forks themselves is not sufficient to result in increased
levels of GCRs when Sgs1 is functional. It should be noted that the
ability of full-length Rrm3 to act as a helicase and the ability of the
Rrm3 helicase domain to unwind DNA substrates other than
duplex DNA have not yet been tested (39).
The higher frequency of GCRs in sgs1mutants as compared with
rrm3 and srs2mutants suggests that Sgs1 has amore significant role
in the regulation of DNA replication andor DNA repair than
either Rrm3 or Srs2. For example, although HR is increased
significantly in both sgs1 and srs2mutants, recombination between
homeologous sequences increases greatly in sgs1mutants but shows
only a very small increase in srs2mutants (11, 66). Lack of Sgs1may
allow recombination between similar DNA sequences by allowing
pairing between homeologous strands as well as by prolonging the
existence of secondary DNA structures, which may normally be
unwound by Sgs1. Lack of Rrm3, which prevents unscheduled
replication fork pausing,may increase the incidence ofDNA lesions
that can be processed to GCRs under some conditions. Our
observation that the Rad9-dependent DNA damage checkpoint
pathway, rather than the Mrc1-dependent replication stress path-
way, activates Rad53 in the absence of Rrm3 also supports the
notion that DNA breaks or single-stranded gaps accumulate in the
absence of Rrm3, possibly because of inappropriate or delayed
repair of replication forks that pause or stall frequently in this
mutant. The lowerGCRrates of sgs1, sgs1 rrm3, and sgs1 rrm3 rad51
mutants compared with the corresponding MEC3-defective mu-
tants indicates that Mec3-dependent checkpoint activation sup-
presses GCRs. That HR mutations suppress GCRs without elim-
inating the checkpoint response suggests that theDNAdamage that
causes Rad53 phosphorylation is not the same DNA damage that
induces GCRs. Indeed, Rad53 phosphorylation in rrm3 mutants
has been associated with impaired replication of tRNA genes,
rDNA, telomeres, centromeres, and mating type loci silencers (34,
37, 39), none of which are present at the chromosome V region
analyzed by our GCR assay; persistence of this DNA damage may
explain Rad53 phosphorylation in sgs1 rrm3 mutants even when
chromosome V-specific GCRs are suppressed by HR mutations.
Lack of Mec3 or Rad24 may allow cell cycle progression in the
presence of unrepaired DNA lesions or during ongoing lesion
repair. The combination of these deficiencies may create a unique
environment for the formation of homeology-driven translocation
events. Indeed, when wemapped and sequenced GCR breakpoints
in the sgs1 rrm3 mec3 mutant we primarily found homeology-
mediated translocations (51). In addition, we found evidence of a
complex rearrangement process that involves exo- and endonucleo-
lytic DNA cleavage, hairpin formation, DNA synthesis, and de novo
telomere addition and results in an inverted sequence (Fig. 5), a
type of rearrangement found thus far only in t (11, 22) translocations
in Ewing’s tumors, which exhibit a high degree of genome-wide
instability (67).
Our study supports the view that three nonreplicative helicases,
Sgs1, Srs2, and Rrm3, act in different ways to control GCRs during
DNA replication: by ensuring replication fork progression (Rrm3
and Sgs1); by preventing secondary structure formation and inter-
and intrachromosomal recombination between related sequences
(Sgs1); and by regulating the formation of recombinogenic Rad51-
filaments (Srs2), emphasizing the importance of both the preven-
tion of illegitimate DNA recombination as well as the limitation of
DNA recombination per se for genome stability and normal cell
proliferation.
Materials and Methods
Plasmids, Yeast Strains, and GCR Rate Measurement. S. cerevisiae
strains used for the determination of mutation rates are derivatives
of S288C. Gene deletions in RDKY3615 (MATa ura3-52 trp163
his3200 leu21 lys2Bgl hom3-10 ade21 ade8, hxt13::URA3),
RDKY5027 (MAT ura3-52 trp163 his3200 leu21 lys2Bgl
hom3-10 ade21 ade8, hxt13::URA3), RDKY2664 (MAT ura3-52
trp163 his3200), RDKY2666 (MATa ura3-52 trp163 his3200),
and their diploid derivatives were generated by HR-mediated
integration of PCR fragments according to standard methods. All
haploid strains used for the determination of mutation rates were
obtained by sporulation of diploids. To minimize the emergence of
suppressors, slow-growing haploid strains were freshly obtained by
sporulation of the appropriate diploid strain for every experiment.
Haploid strains for the analysis of cell-cycle-dependent Rad53
phosphorylation (Fig. 4B) were obtained by sporulation of the
diploid strain YPH501 (MATa, ura3-52ura3-52, lys2-801
amberlys2-801 amber, ade2-101 ochreade2-101 ochre, trp1-63
trp1-63, his3-200his3-200, leu2-1leu2-1; gift from V. Za-
kian, Princeton University) modified to contain heterozygous mu-
tations of interest. To construct RDKY5554, a TRP1 cassette was
inserted into the PacI site 250 bp downstream of themrc1-AQ allele
in plasmid pAO138 (gift from S. Elledge, HarvardMedical School,
Boston, MA) and this mrc1-AQ.TRP1 fragment replaced a URA3
cassette inserted at the MRC1 locus. Successful integration of the
mrc1-AQ allele was confirmed by PCR and sequencing of the entire
mrc1-AQ allele. Strains expressing GFP-tagged Ddc2 were ob-
tained by sporulation of RDKY5581, RDKY5582, and
RDKY5582. Strains containing pds1 or dpb11-1 mutations were
grown at room temperature; all other strains were grown at 30°C.
Strains and their complete genotypes are listed in Table 4, which is
published as supporting information on the PNAS web site. Media
for propagating strains have been described previously (48). GCR
rate measurements and breakpoint analyses were carried out as
described previously (68); statistical significance of differences in
18200  www.pnas.orgcgidoi10.1073pnas.0608566103 Schmidt and Kolodner
GCR rates was evaluated by using the Mann–Whitney test and
programs from R. Lowry at Vasser College (http:faculty.
vassar.edulowryvsord.html).
Microscopy.Live cells were imaged by using a spinning disk confocal
scanhead (McBain Instruments, Chatsworth, CA) on a Nikon
(Tokyo, Japan) TE2000e inverted microscope. Images were ac-
quired using a100, 1.4 N.A. Plan Apo objective lens and an Orca
ER CCD camera (Hamamatsu Photonics, Hamamatsu, Japan)
with 2  2 binning. Acquisition parameters, shutters, and focus
were controlled byMetaMorph software (Universal Imaging). Five
z sections were acquired at 1-m steps. Figures were prepared in
PhotoShop (Adobe Systems, San Jose, CA), and processing pa-
rameterswere kept constant. Thenumber of cells withGFP fociwas
determined by analyzing 200–500 cells.
Cell Cycle Arrest and Western Blot Analysis of Rad53 Phosphorylation.
Cells were grown at 30°C in yeast extractpeptonedextrose media
until they reached OD600  0.5, synchronized in G1 with -factor
(15 gml) and released from arrest by replacing the media with
fresh, prewarmed yeast extractpeptonedextrose. Incubation was
continued at 30°C for 2 h, and aliquots were removed every 15 min
(or aliquots were removed at the beginning and end of a 30-min
incubation) (Fig. 4C) and then put on ice and adjusted for cell
number.Denatured crude extracts were prepared by trichloroacetic
acid extraction (69) and separated on 10% polyacrylamide gels for
Western blot analysis. Polyclonal andmonoclonalRad53 antibodies
were gifts from J. Diffley (Cancer Research UK, London, United
Kingdom) and A. Pellicioli (FIRC Institute ofMolecular Oncology
Foundation, Milan, Italy), respectively.
We thank Paul Maddox (Ludwig Institute for Cancer Research) for help
with confocal microscopy and image analysis; Vincent Pennaneach,
Christopher Putnam, Jorrit Enserinck, and Meng-Er Huang for helpful
comments on the manuscript; Virginia Zakian (Princeton University,
Princeton, NJ) for strain YPH501; Stephen Elledge (Harvard Medical
School, Boston, MA) for plasmid pAO138; J. Diff ley (Cancer Research
UK) for the polyclonal Rad53 antibody JDI47; and A. Pellicioli (FIRC
Institute of Molecular Oncology Foundation) for monoclonal Rad53
antibody EL7. This work was supported by National Institutes of Health
Grant GM26017 (to R.D.K.).
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